Phathom Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 58.3M | 57.6M | 49.5M | 39.5M | 28.5M | 29.7M | 16.4M | 7.3M |
| Cost of Goods Sold | 12.0M | 7.6M | 6.2M | 5.0M | 3.7M | 3.8M | 2.4M | 1.4M |
| Gross Profit | 46.3M | 49.9M | 43.3M | 34.5M | 24.8M | 25.8M | 14.0M | 5.9M |
| R&D Expenses | 7.8M | 7.5M | 7.0M | 9.1M | 9.2M | 8.6M | 8.7M | 7.4M |
| Operating Expenses | 61.8M | 55.9M | 58.6M | 94.4M | 103.7M | 85.3M | 84.8M | 83.2M |
| Operating Income | -15.5M | -5.9M | -15.3M | -59.9M | -78.9M | -59.4M | -70.8M | -77.3M |
| Other Income / Gains | -14.9M | -15.2M | -14.7M | -15.9M | -15.5M | -15.0M | -14.8M | -14.1M |
| Net Income | -30.4M | -21.1M | -30.0M | -75.8M | -94.3M | -74.5M | -85.6M | -91.4M |
| EPS (Diluted) | -0.37 | -0.29 | -0.41 | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.794 | 0.867 | 0.875 | 0.872 | 0.869 | 0.871 | 0.856 | 0.812 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75.9M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 54.0M | 48.4M | 51.6M | 85.3M | 94.5M | 76.7M | 76.1M | 75.9M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 73.8M | 63.5M | 64.8M | 99.4M | 107.4M | 89.1M | 87.1M | 84.6M |
| Interest Income | 1.7M | 1.2M | 1.4M | 1.8M | 2.6M | 3.5M | 3.7M | 3.6M |
| Interest Expense | 15.8M | 16.4M | 16.1M | 17.5M | 18.1M | 18.6M | 18.5M | 17.8M |
| Depreciation And Amortization | 110K | 128K | 156K | 172K | 177K | 193K | 191K | 197K |
| Ebitda | -14.5M | -4.6M | -13.7M | -58.1M | -76.1M | -55.7M | -66.9M | -73.5M |
| Ebitdaratio | -0.248 | -0.08 | -0.277 | -1.471 | -2.667 | -1.877 | -4.091 | -10.033 |
| Operating Income Ratio | -0.265 | -0.103 | -0.308 | -1.517 | -2.765 | -2.003 | -4.33 | -10.554 |
| Income Before Tax | -30.4M | -21.1M | -30.0M | -75.8M | -94.3M | -74.5M | -85.6M | -91.4M |
| Income Before Tax Ratio | -0.521 | -0.367 | -0.605 | -1.919 | -3.307 | -2.51 | -5.233 | -12.486 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.521 | -0.367 | -0.605 | -1.919 | -3.307 | -2.51 | -5.233 | -12.486 |
| Epsdiluted | -0.37 | -0.29 | -0.41 | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 |
| Weighted Average Shs Out | 82.1M | 73.8M | 73.4M | 72.5M | 72.0M | 71.0M | 64.6M | 58.6M |
| Weighted Average Shs Out Dil | 82.1M | 73.8M | 73.4M | 72.5M | 72.0M | 71.0M | 64.6M | 58.6M |